RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16242327http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16242327http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16242327http://www.w3.org/2000/01/rdf-schema#comment"A series of pyrazolopyridazine compounds were briefly investigated as ERK2 inhibitors. The crystal structure of ERK2 complexed with an allyl derivative was determined. The compound induces structural change including movement of the glycine-rich loop and peptide flip between Met108-Glu109. As a result, the newly formed subsite can recognize small hydrophobic substituents but not hydrophilic ones."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.org/dc/terms/identifier"doi:10.1016/j.bmcl.2005.09.055"xsd:string
http://purl.uniprot.org/citations/16242327http://purl.org/dc/terms/identifier"doi:10.1016/j.bmcl.2005.09.055"xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Fujii T."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Fujii T."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Sato K."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Sato K."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Kinoshita T."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Kinoshita T."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Warizaya M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Warizaya M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Neya M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Neya M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Ohori M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/author"Ohori M."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/date"2006"xsd:gYear
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/date"2006"xsd:gYear
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/name"Bioorg. Med. Chem. Lett."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/name"Bioorg. Med. Chem. Lett."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/pages"55-58"xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/pages"55-58"xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/title"Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative."xsd:string
http://purl.uniprot.org/citations/16242327http://purl.uniprot.org/core/title"Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative."xsd:string